Sponsored by National Institutes of Health, the largest clinical trial ever focused on HIV-related cardiovascular disease is still seeking poz participants

As HIV-positive people continue living longer due to highly active antiretroviral therapy, cardiovascular disease has become a growing concern.  According to the National Institute of Allergy and Infectious Diseases, several factors put those with HIV at nearly double the risk of developing heart disease than the non-poz population.

plus.com
Jacob Anderson-Minshall

Read the full article here.